Previous Close | 0.1000 |
Open | 0.1400 |
Bid | 0.1100 |
Ask | 0.1300 |
Strike | 75.00 |
Expire Date | 2022-01-21 |
Day's Range | 0.1300 - 0.1500 |
Contract Range | N/A |
Volume | 1,105 |
Open Interest | 4.9k |
Despite Philip Morris International (NYSE: PM) winning the U.S. Food & Drug Administration (FDA)'s marketing approval and a modified risk label for its IQOS heat-not-burn device, the technology hasn't really gone anywhere.
Altria's (MO) fourth-quarter 2020 results are likely to reflect gains from pricing as well as strength in the Oral Tobacco Products segment, though cigarette volumes have been soft for a while.
Income-oriented investors can still find strong yields if they're willing to venture off the beaten path.